174 related articles for article (PubMed ID: 21044842)
1. Histamine H4 receptor agonists.
Igel P; Dove S; Buschauer A
Bioorg Med Chem Lett; 2010 Dec; 20(24):7191-9. PubMed ID: 21044842
[TBL] [Abstract][Full Text] [Related]
2. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
[TBL] [Abstract][Full Text] [Related]
4. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
[TBL] [Abstract][Full Text] [Related]
5. N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.
Igel P; Schneider E; Schnell D; Elz S; Seifert R; Buschauer A
J Med Chem; 2009 Apr; 52(8):2623-7. PubMed ID: 19317445
[TBL] [Abstract][Full Text] [Related]
6. Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands.
Lee-Dutra A; Arienti KL; Buzard DJ; Hack MD; Khatuya H; Desai PJ; Nguyen S; Thurmond RL; Karlsson L; Edwards JP; Breitenbucher JG
Bioorg Med Chem Lett; 2006 Dec; 16(23):6043-8. PubMed ID: 16990005
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
Schneider EH; Strasser A; Thurmond RL; Seifert R
J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of ligand binding to H4R species variants.
Lim HD; de Graaf C; Jiang W; Sadek P; McGovern PM; Istyastono EP; Bakker RA; de Esch IJ; Thurmond RL; Leurs R
Mol Pharmacol; 2010 May; 77(5):734-43. PubMed ID: 20103609
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists.
Smits RA; Adami M; Istyastono EP; Zuiderveld OP; van Dam CM; de Kanter FJ; Jongejan A; Coruzzi G; Leurs R; de Esch IJ
J Med Chem; 2010 Mar; 53(6):2390-400. PubMed ID: 20192225
[TBL] [Abstract][Full Text] [Related]
10. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.
Savall BM; Edwards JP; Venable JD; Buzard DJ; Thurmond R; Hack M; McGovern P
Bioorg Med Chem Lett; 2010 Jun; 20(11):3367-71. PubMed ID: 20452213
[TBL] [Abstract][Full Text] [Related]
11. Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity.
Wijtmans M; de Graaf C; de Kloe G; Istyastono EP; Smit J; Lim H; Boonnak R; Nijmeijer S; Smits RA; Jongejan A; Zuiderveld O; de Esch IJ; Leurs R
J Med Chem; 2011 Mar; 54(6):1693-703. PubMed ID: 21348462
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
[TBL] [Abstract][Full Text] [Related]
13. Histamine H4 receptor ligands and their potential therapeutic applications.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
[TBL] [Abstract][Full Text] [Related]
14. 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.
Sander K; Kottke T; Tanrikulu Y; Proschak E; Weizel L; Schneider EH; Seifert R; Schneider G; Stark H
Bioorg Med Chem; 2009 Oct; 17(20):7186-96. PubMed ID: 19773175
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
[TBL] [Abstract][Full Text] [Related]
16. Major advances in the development of histamine H4 receptor ligands.
Smits RA; Leurs R; de Esch IJ
Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
[TBL] [Abstract][Full Text] [Related]
17. Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist.
Lim HD; Smits RA; Bakker RA; van Dam CM; de Esch IJ; Leurs R
J Med Chem; 2006 Nov; 49(23):6650-1. PubMed ID: 17154494
[TBL] [Abstract][Full Text] [Related]
18. High-resolution metabolic profiling towards G protein-coupled receptors: rapid and comprehensive screening of histamine H₄ receptor ligands.
Kool J; Rudebeck AF; Fleurbaaij F; Nijmeijer S; Falck D; Smits RA; Vischer HF; Leurs R; Niessen WM
J Chromatogr A; 2012 Oct; 1259():213-20. PubMed ID: 22520160
[TBL] [Abstract][Full Text] [Related]
19. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]